Panbela Therapeutics Inc PBLA
$0.00
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
PBLA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Panbela Therapeutics Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
Panbela Therapeutics Inc. Stock Analysis PBLA
United States Health Care Nano Cap Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. The company is headquartered in Waconia, Minnesota and currently employs 7 full-time employees. The company went IPO on 2014-07-29. The firm is developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company’s lead candidates are ivospemin (SBP-101), for which it has licensed the worldwide rights from the University of Florida Research Foundation, Inc., Flynpovi, a combination of eflornithine (CPP-1X) and sulindac and eflornithine (CPP-1X), alone in tablet or sachet form. The company has licensed rights from the Arizona Board of Regents of the University of Arizona to commercialize Flynpovi. Additionally, eflornithine is being evaluated with high dose testosterone and enzalutamide in metastatic castration-resistant prostate cancer in a phase II trial. The firm is engaged in over two sponsored research agreements to evaluate the polyamines individually and combined for various diseases.
Panbela Therapeutics Inc (PBLA) Chart
Financial Metrics & Statements of Panbela Therapeutics Inc (PBLA)
FAQ's for Panbela Therapeutics Inc (PBLA)
- As of August 2026, Panbela Therapeutics Inc PBLA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Panbela Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Panbela Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Panbela Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Panbela Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Panbela Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Panbela Therapeutics Inc (PBLA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
